Does APALUTAMIDE Cause Product dose omission issue? 384 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 384 reports of Product dose omission issue have been filed in association with APALUTAMIDE (ERLEADA). This represents 4.0% of all adverse event reports for APALUTAMIDE.
384
Reports of Product dose omission issue with APALUTAMIDE
4.0%
of all APALUTAMIDE reports
1
Deaths
24
Hospitalizations
How Dangerous Is Product dose omission issue From APALUTAMIDE?
Of the 384 reports, 1 (0.3%) resulted in death, 24 (6.3%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APALUTAMIDE. However, 384 reports have been filed with the FAERS database.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
Decreased appetite (255)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which APALUTAMIDE Alternatives Have Lower Product dose omission issue Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN